Component: (Network and Table)
Network
00200 - Statement - Consolidated Statements of Operations
(http://www.diplomat.is/role/StatementConsolidatedStatementsOfOperations)
Table(Implied)
Slicers (applies to each fact value in each table cell)
Reporting Entity [Axis]0001610092 (http://www.sec.gov/CIK)
Consolidated Statements of OperationsPeriod [Axis]
2016-01-01 - 2016-12-31
2015-01-01 - 2015-12-31
2014-01-01 - 2014-12-31
Consolidated Statements of Operations
 
 
 
Net sales
4,410,388,000  
3,366,631,000  
2,214,956,000  
Cost of products sold
(4,085,560,000) 
(3,103,392,000) 
(2,074,817,000) 
Gross profit
324,828,000  
 
263,239,000  
 
140,139,000  
 
Selling, general, and administrative expenses
(277,751,000) 
(217,302,000) 
(127,556,000) 
Income from operations
47,077,000  
 
45,937,000  
 
12,583,000  
 
Other (expense) income:
 
 
 
Interest expense
(6,573,000) 
(5,239,000) 
(2,528,000) 
Equity loss and impairment of non-consolidated entities
(4,659,000) 
 
(6,208,000) 
Change in fair value of redeemable common shares
  
9,073,000  
Termination of existing stock redemption agreement
  
(4,842,000) 
Other
370,000  
308,000  
1,128,000  
Total other expense
(10,862,000) 
 
(4,931,000) 
 
(3,377,000) 
 
Income before income taxes
36,215,000  
 
41,006,000  
 
9,206,000  
 
Income tax expense
(11,195,000) 
(16,234,000) 
(4,655,000) 
Net income
25,020,000  
 
24,772,000  
 
4,551,000  
 
Less net loss attributable to noncontrolling interest
(3,253,000) 
(1,004,000) 
(225,000) 
Net income attributable to Diplomat Pharmacy, Inc.
28,273,000  
 
25,776,000  
 
4,776,000  
 
Net income allocable to preferred shareholders
  
458,000  
Net income allocable to common shareholders
28,273,000  
25,776,000  
4,318,000  
Net income per common share:
 
 
 
Basic (in dollars per share)
.43  
.42  
.12  
Diluted (in dollars per share)
.42  
.41  
.11  
Weighted average common shares outstanding:
 
 
 
Basic (in shares)
65,970,396  
60,730,133  
36,012,592  
Diluted (in shares)
68,047,723  
63,096,951  
38,553,995